218 related articles for article (PubMed ID: 6304026)
21. Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.
Galizzi JP; Borsotto M; Barhanin J; Fosset M; Lazdunski M
J Biol Chem; 1986 Jan; 261(3):1393-7. PubMed ID: 3003067
[TBL] [Abstract][Full Text] [Related]
22. SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.
Schmid A; Romey G; Barhanin J; Lazdunski M
Mol Pharmacol; 1989 Jun; 35(6):766-73. PubMed ID: 2543910
[TBL] [Abstract][Full Text] [Related]
23. Purification of the dihydropyridine receptor of the voltage-dependent Ca2+ channel from skeletal muscle transverse tubules using (+) [3H]PN 200-110.
Borsotto M; Barhanin J; Norman RI; Lazdunski M
Biochem Biophys Res Commun; 1984 Aug; 122(3):1357-66. PubMed ID: 6089781
[TBL] [Abstract][Full Text] [Related]
24. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
Ferry DR; Goll A; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
[TBL] [Abstract][Full Text] [Related]
25. A calcium antagonist drug binding site in skeletal muscle sarcoplasmic reticulum: evidence for a calcium channel.
Fairhurst AS; Thayer SA; Colker JE; Beatty DA
Life Sci; 1983 Mar; 32(12):1331-9. PubMed ID: 6300579
[TBL] [Abstract][Full Text] [Related]
26. Dihydropyridine [methyl-3H]PN 200-110 binding and myogenesis in intact muscle cells in vitro.
Navarro J
J Neurochem; 1986 Apr; 46(4):1166-9. PubMed ID: 3005507
[TBL] [Abstract][Full Text] [Related]
27. Altered transverse tubule dihydropyridine receptor binding in malignant hyperthermia.
Ervasti JM; Claessens MT; Mickelson JR; Louis CF
J Biol Chem; 1989 Feb; 264(5):2711-7. PubMed ID: 2536721
[TBL] [Abstract][Full Text] [Related]
28. High affinity binding sites for [3H]-nitrendipine in rabbit uterine smooth muscle.
Miller WC; Moore JB
Life Sci; 1984 Apr; 34(18):1717-24. PubMed ID: 6727544
[TBL] [Abstract][Full Text] [Related]
29. Direct photoaffinity labeling of the high affinity nitrendipine-binding site in subcellular membrane fractions isolated from canine myocardium.
Campbell KP; Lipshutz GM; Denney GH
J Biol Chem; 1984 May; 259(9):5384-7. PubMed ID: 6325434
[TBL] [Abstract][Full Text] [Related]
30. Ion pathways in transverse tubules. Quantification of receptors in membranes isolated from frog and rabbit skeletal muscle.
Jaimovich E; Donoso P; Liberona JL; Hidalgo C
Biochim Biophys Acta; 1986 Feb; 855(1):89-98. PubMed ID: 3002475
[TBL] [Abstract][Full Text] [Related]
31. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
[TBL] [Abstract][Full Text] [Related]
32. Specific binding of the calcium antagonist [3H]verapamil to membrane fractions from plants.
Andrejauskas E; Hertel R; Marmé D
J Biol Chem; 1985 May; 260(9):5411-4. PubMed ID: 3157687
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
Dunn SM; Bladen C
Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
[TBL] [Abstract][Full Text] [Related]
34. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
Bellemann P
J Recept Res; 1984; 4(1-6):571-85. PubMed ID: 6084713
[TBL] [Abstract][Full Text] [Related]
35. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats.
Ehlert FJ; Roeske WR; Itoga E; Yamamura HI
Life Sci; 1982 Jun; 30(25):2191-202. PubMed ID: 7109844
[TBL] [Abstract][Full Text] [Related]
36. Subcellular distribution of [3H]nitrendipine binding in smooth muscle.
Grover AK; Kwan CY; Luchowski E; Daniel EE; Triggle DJ
J Biol Chem; 1984 Feb; 259(4):2223-6. PubMed ID: 6321463
[TBL] [Abstract][Full Text] [Related]
37. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W
Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392
[TBL] [Abstract][Full Text] [Related]
38. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
Gould RJ; Murphy KM; Snyder SH
Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
[TBL] [Abstract][Full Text] [Related]
39. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
Lee HR; Roeske WR; Yamamura HI
Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
[TBL] [Abstract][Full Text] [Related]
40. Target size analysis and molecular properties of Ca2+ channels labelled with [3H]verapamil.
Goll A; Ferry DR; Glossmann H
Eur J Biochem; 1984 May; 141(1):177-86. PubMed ID: 6327306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
